MC

Mayank Chouhan

Active Director Designated Partner DIN 11114311
DIN 11114311 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayank Chouhan

Data last updated:

Mayank Chouhan is a Designated Partner at Maa Narmada Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11114311
Primary Designation Designated Partner
Industry Pharma
First Appointment 19 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 May 20252025Active

Board colleagues of Mayank Chouhan

NameDINCompanyDesignation
Akash Dwivedi10016585Maa Narmada Pharmaceuticals LlpDesignated Partner
Durgesh Tiwari11114310Maa Narmada Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Maa Narmada Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Mayank Chouhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayank Chouhan

Mayank Chouhan currently holds 1 directorship: Maa Narmada Pharmaceuticals Llp (Designated Partner, since 19 May 2025).

Mayank Chouhan was first appointed on 19 May 2025 as Designated Partner at Maa Narmada Pharmaceuticals Llp.

The current boards of Mayank Chouhan's companies include Akash Dwivedi (Maa Narmada Pharmaceuticals Llp), Durgesh Tiwari (Maa Narmada Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available